1CHANDRASEKAR P H,MANAVATHU E,VORICONAZOLE A.Second-generation trizole[J].Drugs Today,2001,37(2):135-148.
2YUET W.Voriconazole versus amphotericin for primary therapy of invasive aspergillosis[J].N Engl J Med,2002,347(6):408-415.
3HOFFMAN H L,RATHBURN R C.Review of the safety and efficacy of voriconazole[J].Expert Opin Investig Drugs,2002,11():409-429.
4POTOSKI B A,BROWN J.The safety of voriconazole[J].Clin Infect Dis,2002,35(10):1273-1275.
5ULLMANN A J.Review of the safety,tolerability,and drug interactions of the new antifungal agents caspofungin and voriconazole[J].Curr Med Res Opin,2003,19(4):263-271.
6GUPTA A K,TOMAS E.New antifungal agents[J].Dermatol Clin,2003,21(3):565-76.
7FLOREA N R,KUTI J L,QUINTILIANE R.Voriconazole:a novel azole antifungal[J].Formulary,2002,37:1-10.
8SABO J A,ABDEL-RAHMAN S M.Voriconazole:a new triazole antifungal[J].Ann Pharmacother,2000,34(9):1032-1043.
9JEU L,PIACENTI F J,LYAKHOVETSKIY A G,et al.Voriconazole[J].Clin Ther,2003,25(5):1321-381.
10CHANDRASEKAR P H,MANAVATHU E.Voriconazole:a second-generation triazole[J].Drugs Today (Barc),2001,37(2):135-148.
